|
Cytarabine This page contains brief information about cytarabine and a collection of links to more information from the National Cancer Institute (NCI), the Food and Drug Administration (FDA), and the National Library of Medicine (NLM). | US Brand Name(s): |  | Cytosar-U | | | | Tarabine PFS | | | | FDA Approved: | | Yes |
Cytarabine is approved by the Food and Drug Administration (FDA) to be given as intrathecal therapy to prevent and treat meningeal leukemia (leukemia that has spread to the meninges). Cytarabine is also approved to be used together with other drugs to treat the following conditions: Cytarabine is being studied in the treatment of other types of cancer.
Cytarabine is also available in a different form called liposomal cytarabine. For more information, see the Drug Information Summary for Liposomal Cytarabine. Information from the NCIDefinition from the NCI Drug Dictionary - Detailed scientific definition and other names for this drug.
Clinical Trial Results: Low-Dose Cytarabine Improves Survival of Older Patients with Leukemia (03/27/2007) - Important clinical trial results for this drug, background information, and how the trial was done.
Information from the NLM
MedlinePlus Information on Cytarabine - A lay language summary of important information about this drug that may include the following:
- warnings about this drug,
- what this drug is used for and how it is used,
- what you should tell your doctor before using this drug,
- what you should know about this drug before using it,
- other drugs that may interact with this drug, and
- possible side effects.
Drugs are often studied to find out if they can help treat or prevent conditions other than the ones they are approved for. This NLM patient information sheet applies only to approved uses of the drug. However, much of the information may also apply to unapproved uses that are being studied. Clinical TrialsClinical Trials for Cytarabine - Check for trials from NCI's PDQ Cancer Clinical Trials Registry now accepting patients.
Important: The drug information on this Web page is meant to be educational. It is not a substitute for medical advice. The information may not cover all possible uses, actions, interactions, or side effects of this drug, or precautions to be taken while using it. Please see your health care professional for more information about your specific medical condition and the use of this drug.
 Back to Top |
